OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 144

Showing 26-50 of 144 citing articles:

Integrating Hydrogen Exchange with Molecular Dynamics for Improved Ligand Binding Predictions
Benjamin T. Walters, Alexander W. Patapoff, James R. Kiefer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Leveraging AI to Explore Structural Contexts of Post-Translational Modifications in Drug Binding
Kirill E. Medvedev, R. Dustin Schaeffer, Nick V. Grishin
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

One-pot modular nanogel platform utilizing phenolic gelatin-polyethyleneimine for small RNA delivery
Kyoungmin Park, Jie Zheng, Jeong-Eun Yoo, et al.
Chemical Engineering Journal (2025), pp. 159532-159532
Closed Access

Hyaluronic acid-silybin conjugate for the preparation of multifunctional, biomimetic, vancomycin-loaded self-assembled polymersomes against bacterial sepsis
Mohammed A. Gafar, Calvin A. Omolo, Usri H. Ibrahim, et al.
International Journal of Biological Macromolecules (2025) Vol. 299, pp. 140152-140152
Closed Access

Purine-rich element binding protein alpha: a DNA/RNA binding protein with multiple roles in cancers
Shiyi Yu, Chengyang Jiang, Yawen Yang, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access

Fragment-based drug discovery: Small fragments, big impact − Success stories of approved oncology therapeutics
Nilesh Raghunath Khedkar, Milind Sindkhedkar, Alex Joseph
Bioorganic Chemistry (2025) Vol. 156, pp. 108197-108197
Closed Access

Protocol for Oligonucleotides Characterization Using Hydrophilic Interaction Chromatography
Davy Guillarme, Szabolcs Fekete, Sylwia Studzińska
Journal of Separation Science (2025) Vol. 48, Iss. 1
Closed Access

Versatile One-Pot Synthesis of Hydrophobic Tags by Multicomponent Reactions
Federica Carolina Balestrero, Laura Gioiello, Georgia Goutsiou, et al.
ACS Omega (2025) Vol. 10, Iss. 5, pp. 4745-4753
Open Access

Advancing brain tumor therapy: unveiling the potential of PROTACs for targeted protein degradation
S.M. Ibrahim, Muhammad Umer Khan, Saadia Noreen, et al.
Cytotechnology (2025) Vol. 77, Iss. 2
Closed Access

Navigating PROTACs in Cancer Therapy: Advancements, Challenges, and Future Horizons
S.M. Ibrahim, Muhammad Umer Khan, Iqra Khurram, et al.
Food Science & Nutrition (2025) Vol. 13, Iss. 2
Open Access

A Medicinal Chemistry Perspective on FDA-Approved Small Molecule Drugs with a Covalent Mechanism of Action
Samuel E. Dalton, Ornella Di Pietro, Elisabeth T. Hennessy
Journal of Medicinal Chemistry (2025)
Closed Access

ZFP-CanPred: Predicting the effect of mutations in zinc-finger proteins in cancers using protein language models
Adhuna Phogat, Sowmya Ramaswamy Krishnan, Medha Pandey, et al.
Methods (2025)
Closed Access

PROTACs coupled with oligonucleotides to tackle the undruggable
Guangshuai Zhang, Si Yan, Yan Liu, et al.
Bioanalysis (2025), pp. 1-16
Closed Access

The structure of a NEMO construct engineered for screening reveals novel determinants of inhibition
Amy E. Kennedy, Adam H. Barczewski, Christina R. Arnoldy, et al.
Structure (2025)
Open Access

Phosphodegrons in Health and Disease: From Cellular Homeostasis to Therapeutic Potential
Tadashi Nakagawa, Makiko Nakagawa
Kinases and Phosphatases (2025) Vol. 3, Iss. 1, pp. 3-3
Open Access

Peptide-driven strategies against lung cancer
Vijayshree S Karankar, Saurabh Awasthi, Nidhi Srivastava
Life Sciences (2025), pp. 123453-123453
Closed Access

STAT signaling in the pathogenesis and therapy of acute myeloid leukemia and myelodysplastic syndromes
Zoe King, Sudhamsh Reddy Desai, David A. Frank, et al.
Neoplasia (2025) Vol. 61, pp. 101137-101137
Closed Access

New strategies to enhance the efficiency and precision of drug discovery
Qi An, Liang Huang, Chuan Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Feature Reviews in Medicinal Chemistry
Mary J. Meegan
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 260-260
Open Access

MMRT: MultiMut Recursive Tree for prediction of functional effects of high-order protein variants from low-order variants
Bruce J. Forrest, Houssemeddine Derbel, Zhongming Zhao, et al.
Computational and Structural Biotechnology Journal (2025) Vol. 27, pp. 672-681
Open Access

Omics Approaches to Drug and Drug-Non-Drug Interactions
Angela Adamski da Silva Reis, Rodrigo da Silva Santos
(2025), pp. 261-290
Closed Access

Untangling the Role of MYC in Sarcomas and Its Potential as a Promising Therapeutic Target
Fabio Sias, Stefano Zoroddu, Rossana Migheli, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1973-1973
Open Access

Scroll to top